Showing 6,080 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Undetectable viral load & treatment as prevention

I'm A Grandmother, I Have HIV, And I Can't Pass It On

Editor's pick
HuffPost UK
19 July 2017
Treatment outcomes & life expectancy

Viral Rebound Unlikely for Many on ART

Editor's pick
Infectious Disease Special Edition
14 July 2017
Side effects

Proton pump inhibitors may blunt CD4 cell gains, cause immune activation, in people with HIV

News
13 July 2017
Hepatitis & HIV

Non-alcoholic fatty liver disease common in people living with HIV – metabolic disorders are key risk factors

News
12 July 2017
Sexually transmitted infections epidemiology

Oral sex spreading unstoppable bacteria

Editor's pick
BBC
7 July 2017
Treatment outcomes & life expectancy

Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

News
5 July 2017
Retention & linkage to care

Why are women lost from HIV care during pregnancy? Malawi study shows social support and counselling are critical

News
28 June 2017
Access to healthcare

Kenya to introduce better treatment for people living with HIV

Editor's pick
UNITAID
28 June 2017
HIV treatment for children & young people

HIV drug resistance becoming more common in Zambian infants

News
27 June 2017
Access to healthcare

Dolutegavir access in the Asia-Pacific region

Editor's pick
amfAR Treat Asia
27 June 2017
Side effects

Medicine information leaflets 'too scary', say experts

Editor's pick
BBC Health
20 June 2017
Bad science & bogus treatments

Top HIV expert is not donating to crowdfunding HIV vaccine campaign, says it's "Fake News"

Editor's pick
imstilljosh
17 June 2017
Resistance

HIV drug resistance testing not a priority for resource-limited settings, trial finds

News
14 June 2017
Adherence

SA's new HIV challenge: patients who believe they've been healed

Editor's pick
Citizen
13 June 2017
PrEP science

Long-acting Injectable Antiretrovirals for PrEP: Will the tail wag the drug?

Editor's pick
AVAC
9 June 2017
Global health targets

Study: 1 in 3 Patients Starts HIV Treatment Late in 10 Countries

Editor's pick
Voice of America
9 June 2017
Treatment for women

Meds May Impact Prenatal Screening in HIV+ Patients

Editor's pick
MedPage Today HIV/AIDS
8 June 2017
Resistance

Experts raise concerns over high HIV treatment failure in Kenya

Editor's pick
The Standard
6 June 2017
New & experimental HIV treatments

ViiV Healthcare Files Regulatory Submissions for First Two-Drug HIV Maintenance Regimen

Editor's pick
ViiV
2 June 2017
Changing treatment

HIV: A therapeutic advance for resource-limited settings

Editor's pick
Eurekalert Inf Dis
31 May 2017
Pharmaceutical industry

Gilead and GSK go head-to-head with similar HIV drug data

Editor's pick
Reuters
31 May 2017
New & experimental HIV treatments

Gilead’s Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for the Treatment of HIV-1 Meets Primary Endpoint in Four Phase 3 Studies

Editor's pick
Gilead press release
30 May 2017
Adherence

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

News
30 May 2017
Contraception

Taking Birth Control With HIV Treatment or PrEP Is Largely OK

Editor's pick
Poz
30 May 2017